Nycomed's preclinical anti-cancer program sold to Bayer Schering Pharma
- Details
- Category: Nycomed

Lipitor 80 mg Reduced the Risk of Heart Attack and Stroke
- Details
- Category: Pfizer

Closure of the tipranavir trials SPRING and TICINO
- Details
- Category: Boehringer Ingelheim

Novo Nordisk employee suspended after being charged with insider trading
- Details
- Category: Novo Nordisk

First interleukin-6 inhibitor (IL-6) to offer new therapeutic option for rheumatoid arthritis
- Details
- Category: Roche

Significant blood pressure reductions seen with Exforge across difficult-to-treat groups
- Details
- Category: Novartis

GlaxoSmithKline and the Harvard Stem Cell Institute announce a unique collaboration
- Details
- Category: GlaxoSmithKline

More Pharma News ...
- Nexavar Approved for Treatment of Liver Cancer in China
- Nexavar Study Demonstrates Significant Improvement in Overall Survival
- Pfizer Reports Second-Quarter 2008 Results
- GlaxoSmithKline teams up with academia to develop new medicines of value
- Novartis gains momentum with strong performance in first half of 2008
- Abbott Reports Stronger-than-Expected Sales and Earnings Growth in Second Quarter
- Boehringer Ingelheim FENS Award for exceptional research in neuroscience